TP53 and squamous cell carcinoma: The currently accruing STRIVE trial [STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision (STRIVE)] is a prospective study to determine if implementation of HPV (p16) and p53 stratified surgical margin management will improve outcomes.